Skin can show first signs of diabetes

Certain skin conditions commonly seen in dermatology practice, can often be the first signs that a patient has diabetes, said Dr Rakesh Newaj, dermatologist in private practice in Gauteng.

 

Medical Chronicle August 2019 CPDs

These are both CPDs produced for the August 2019 issue of Medical Chronicle, accredited for 3 points. This month’s CPDs focus on dry skin and skin integrity, and the cardiovascular complications of diabetes.

Cardiovascular risk reduction in diabetes mellitus

Globally significant increase in the prevalence of diabetes has been documented and this increase is expected to impact in a major way on health costs, economic costs and quality of life. Diabetes is a complex disease which leads to a multifactorial treatment strategy.

Immune cell linked to type 1 diabetes

A research team from Johns Hopkins Medicine has been the first to document the existence of the long searched-for ‘X cell,’ a ‘rogue hybrid’ immune system cell that may play a key role in the development of type 1 diabetes.

Insulin pens: what do patients prefer?

The use of pens as the preferred means of insulin delivery has become standard over the course of the last decade. Given the importance of adherence to therapy in diabetes management, physicians must keep a patient’s preference in mind.

Read More
CPD POINTS: 1

Lies, damn lies and statistics

Epidemiological studies have long suggested a correlation between hyperglycaemia and higher rates of cardiovascular disease (CVD). Meta-analysis of these studies shows that a 1% increase in Hba1c increases CVD risk by 18%.

Gla-300 Vs IDeg-100: What the first RCT says

MEDICAL CHRONICLE OCTOBER CPD 3 of 4: The BRIGHT study results reflect positively on these second-generation longer-acting basal insulin analogues, both of which reduced HbA1c, glucose profiles and fasting SMPG.

How to combat statin-associated muscle symptoms

MEDICAL CHRONICLE OCTOBER CPD 4 of 4: Despite some potentially severe side effects, statins are possibly the most effective drugs for the prevention and treatment of hypercholesterolemia and coronary heart disease.

Medical Chronicle October CPDs

Below are all of the CPDs produced for the October 2018 issue of Medical Chronicle. You need to read all 4, then complete a questionnaire for a combined total of 3 CPD points.

Vitamin B deficiency in patients with diabetes

SPECIALIST FORUM AUGUST CPD 1 of 4: Vitamins are actively involved in many metabolic processes of the nervous system. Their deficit may cause severe and, sometimes, irreversible consequences for diabetic patients.

Specialist Forum August CPDs

These are the Specialist Forum’s August CPDs. Click on the questionnaire below to start the CPD quiz.

Supplementing diabetic patients

MEDICAL CHRONICLE JULY 2018: CPD 4 of 5

What is new about SGLT-2 inhibitors?

MEDICAL CHRONICLE JULY 2018: CPD 3 of 5

Medical Chronicle July CPDs

These are the Medical Chronicle’s July CPDs. Click on the questionnaire below to start the CPD quiz.

New insulin reduces nocturnal hypoglycaemia

Sanofi is the first company in South African medical history to introduce a newly launched product available at the cost of a clone.

That sugar high

In January 2018 the American Diabetes Association (ADA) updated their Standards of Medical Care for the treatment of type 1 diabetes and diabetes mellitus type 2 (DMT2).

Safety, efficacy of Biosimilar human insulins

Diabetes mellitus (diabetes) affects people worldwide and poses major public health and socio-economic challenges. The disorder was previously thought to be rare or undocumented in rural Africa, but over the past few decades it has emerged as an important non-communicable disease (NCD) in sub-Saharan Africa (SSA).

Achieving glycaemic control

Diabetes is South Africa’s second biggest killer but there is a critical lack of consensus among experts and policymakers about how this growing epidemic should be tackled.

A new era in the management of type 2 Diabetes

Various studies have thrust the sodium glucose cotransporter 2 (SGLT2) inhibitors (‘gliflozin’) into the forefront of T2DM guidelines.

Managing a monster

Diabetes is a life-long disease that affects the way the body handles glucose, a sugar in the blood. Most people with the condition have type 2. Type 2 diabetes has been increasing substantially over the last 20 years.

« » page 1 / 2